Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation

Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemotherapy induces a rapid regression of metastases, immunotherapy generates systemic anticancer immunity, contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerlini, Gianni, Di Gennaro, Paola, Borgognoni, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525636/
https://www.ncbi.nlm.nih.gov/pubmed/23264927
http://dx.doi.org/10.4161/onci.21991
_version_ 1782253453010010112
author Gerlini, Gianni
Di Gennaro, Paola
Borgognoni, Lorenzo
author_facet Gerlini, Gianni
Di Gennaro, Paola
Borgognoni, Lorenzo
author_sort Gerlini, Gianni
collection PubMed
description Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemotherapy induces a rapid regression of metastases, immunotherapy generates systemic anticancer immunity, contributes to eradicate the tumor and maintains an immunological memory to control relapse.
format Online
Article
Text
id pubmed-3525636
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-35256362012-12-21 Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation Gerlini, Gianni Di Gennaro, Paola Borgognoni, Lorenzo Oncoimmunology Author's View Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemotherapy induces a rapid regression of metastases, immunotherapy generates systemic anticancer immunity, contributes to eradicate the tumor and maintains an immunological memory to control relapse. Landes Bioscience 2012-12-01 /pmc/articles/PMC3525636/ /pubmed/23264927 http://dx.doi.org/10.4161/onci.21991 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Gerlini, Gianni
Di Gennaro, Paola
Borgognoni, Lorenzo
Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title_full Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title_fullStr Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title_full_unstemmed Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title_short Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
title_sort enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525636/
https://www.ncbi.nlm.nih.gov/pubmed/23264927
http://dx.doi.org/10.4161/onci.21991
work_keys_str_mv AT gerlinigianni enhancingantimelanomaimmunitybyelectrochemotherapyandinvivodendriticcellactivation
AT digennaropaola enhancingantimelanomaimmunitybyelectrochemotherapyandinvivodendriticcellactivation
AT borgognonilorenzo enhancingantimelanomaimmunitybyelectrochemotherapyandinvivodendriticcellactivation

Ejemplares similares